“Target Long-Term Responders in Indolent Non-Hodgkin’s Lymphoma: 90Y-Ibritumomabtiuxetan”. Hematology Meeting Reports 2, no. 7 (June 8, 2009). Accessed August 12, 2025. https://journals.pagepress.org/hmr/article/view/396.